Global CRO known for regulatory-led strategy and end-to-end clinical development support.
Vendor description
Best suited for sponsors that need deep clinical and regulatory support with established global delivery.
Programs with heavy regulatory complexity and global filings.
- Regulatory depth
- Consultative support
- Pricing pressure for smaller biotech budgets
Approved customer reviews
Write a reviewBe the first customer to share verified experience with this vendor.
Review snapshot
Parexels public employee signal is generally positive but demanding. CRA-specific reviews are stronger than average and employees often describe it as a good place to enter or build a clinical-research career when the team is supportive,but compensation progression,metrics pressure,and workload expectations come up repeatedly. Overall,it looks better than many peers,though not easy.
Strong CRA experience - entry/career-building value - supportive teams - entry - career-building value
Salary progression - metrics pressure - workload
Mixed-positive
Pricing
$
premium
Key facts
| HQ country | United States |
|---|---|
| Geography | Global |
| Service model | Full-service |
| Customer segment | mixed |
| Study phases | Phase I, Phase II, Phase III, Phase IV |
| Trial scale | Large and mid-size global development programmes |
| Therapeutic areas | Oncology, Neuroscience, Rare disease, Generalist |
| Last reviewed | 2026-03-28 |
Related vendors
Editorial ranking
See how Parexel compares - best Full-service CRO vendors for clinical trials.




